Immunogenicity of BNT162b2 vaccine booster againstSARS-CoV-2 Delta and Omicron variants in nursinghome residents: A prospective observational study inolder adults aged from 68 to 98 years

被引:20
作者
Alidjinou, Enagnon Kazali [1 ]
Demaret, Julie [2 ]
Corroyer-Simovic, Benedicte [3 ]
Labreuche, Julien [4 ]
Goffard, Anne [5 ,6 ]
Trauet, Jacques [2 ]
Lupau, Daniela [2 ]
Miczek, Sophie [7 ]
Vuotto, Fanny [8 ]
Dendooven, Arnaud [2 ]
Huvent-Grelle, Dominique [3 ]
Podvin, Juliette [3 ]
Dreuil, Daniel [3 ]
Faure, Karine [8 ]
Deplanque, Dominique [9 ]
Bocket, Laurence [1 ]
Duhamel, Alain [10 ]
Sobaszek, Annie [11 ]
Hober, Didier [1 ]
Hisbergues, Michael [12 ]
Puisieux, Francois [3 ]
Autran, Brigitte [13 ,14 ]
Yazdanpanah, Yazdan [15 ]
Labalette, Myriam [2 ]
Lefevre, Guillaume [2 ]
机构
[1] CHU Lille, Lab Virol ULR3610, Univ Lille, F-59000 Lille, France
[2] Univ Lille, CHU Lille, Inst Immunol, U1286 Infinite Inst Translat Res Inflammat,Inserm, F-59000 Lille, France
[3] Univ Lille, CHU Lille, Hop Geriatr Bateliers, Pole Geriatrie, F-59000 Lille, France
[4] CHU Lille, Dept Biostat, F-59000 Lille, France
[5] Univ Lille, CIIL U1019 CIIL Ctr Infect & Immunite Lille, Ctr Infect & Immunite Lille, CNRS,Inserm,CHU Lille,Inst Pasteur Lille,U1019,UM, F-59000 Lille, France
[6] Inst Pasteur, Clin Microbiol Unit, F-59000 Lille, France
[7] CHU Lille, Med & Sante Travail, F-59000 Lille, France
[8] CHU Lille, Dept Malad Infect, F-59000 Lille, France
[9] Univ Lille, CHU Lille, Inserm, CIC 1403 Clin Invest Ctr, F-59000 Lille, France
[10] Univ Lille, EA 2694 Sante Publ Epidemiol & Qualite Soins, CHU Lille, Lille, Hauts De France, France
[11] Univ Lille, ULR 4483, Med & Sante Travail, IMPECS,CHU Lille, F-59000 Lille, France
[12] Univ Lille, Ctr Ressources Biol, CHU Lille, F-59000 Lille, France
[13] Sorbonne Univ, Paris, France
[14] CIMI Paris Ctr Rech Immunite Malad Infect, UMR S Inserm UPMC 1135, Paris, France
[15] Hop Bichat Claude Bernard, Infect Dis Dept, IAME, INSERM, Paris, France
来源
LANCET REGIONAL HEALTH-EUROPE | 2022年 / 17卷
关键词
BNT162b2; vaccine; Boost; SARS-CoV-2; Delta; Omicron; Older people; immunogenicity; FRAILTY;
D O I
10.1016/j.lanepe.2022.100385
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Background The present study aimed to evaluate the persistent immunogenicity offered by a third dose of BNT162b2 against Delta and Omicron variants, in nursing home (NH) residents. Methods In this monocenter prospective observational study, anti-spike IgG levels, S1 domain reactive T cell counts, serum neutralizing antibody titers against Delta and Omicron variants were compared before and up to three months after the BNT162b2 booster dose, in NH residents without COVID-19 (COVID-19 naive) or with COVID-19 prior to initial vaccination (COVID-19 recovered). Findings 106 NH residents (median [interquartile range] age: 86.5 [81;91] years) were included. The booster dose induced a high increase of anti-spike antibody levels in all subjects (p < 0.0001) and a mild transient increase of specific T cells. Before the booster dose, Delta neutralization was detected in 19% (n = 8/43) and 88% (n = 37/42) of COVID-19 naive and COVID-19 recovered subjects, respectively. Three months after the booster dose, all NH residents developed and maintained a higher Delta neutralization (p < 0.0001). Before the booster dose, Omicron neutralization was detected in 5% (n = 2/43) and 55% (n = 23/42) of COVID-19 naive and COVID-19 recovered subjects, respectively, and three months after, in 84% and 95%, respectively. Neutralizing titers to Omicron were lower than to Delta in both groups with a 35-fold reduction compared to Delta. Interpretation The booster dose restores high neutralization titers against Delta in all NH residents, and at a lower level against Omicron in a large majority of participants. Future studies are warranted to assess if repeated BNT162b2 booster doses or new specific vaccines might be considered for protecting such fragile patients against Omicron and/or future SARS-CoV-2 variants. Copyright (C) 2022 The Authors. Published by Elsevier Ltd.
引用
收藏
页数:10
相关论文
共 26 条
[1]   Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost [J].
Ai, Jingwen ;
Zhang, Haocheng ;
Zhang, Yi ;
Lin, Ke ;
Zhang, Yanliang ;
Wu, Jing ;
Wan, Yanming ;
Huang, Yanfang ;
Song, Jieyu ;
Fu, Zhangfan ;
Wang, Hongyu ;
Guo, Jingxin ;
Jiang, Ning ;
Fan, Mingxiang ;
Zhou, Yang ;
Zhao, Yuanhan ;
Zhang, Qiran ;
Liu, Qiang ;
Lv, Jing ;
Li, Peiyao ;
Qiu, Chao ;
Zhang, Wenhong .
EMERGING MICROBES & INFECTIONS, 2022, 11 (01) :337-343
[2]   Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients [J].
Bouillanne, O ;
Morineau, G ;
Dupont, C ;
Coulombel, I ;
Vincent, JP ;
Nicolis, I ;
Benazeth, S ;
Cynober, L ;
Aussel, C .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2005, 82 (04) :777-783
[3]   Reduced BNT162b2 Messenger RNA Vaccine Response in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Naive Nursing Home Residents [J].
Canaday, David H. ;
Carias, Lenore ;
Oyebanji, Oladayo A. ;
Keresztesy, Debbie ;
Wilk, Dennis ;
Payne, Michael ;
Aung, Htin ;
St Denis, Kerri ;
Lam, Evan C. ;
Rowley, Christopher F. ;
Berry, Sarah D. ;
Cameron, Cheryl M. ;
Cameron, Mark J. ;
Wilson, Brigid ;
Balazs, Alejandro B. ;
Gravenstein, Stefan ;
King, Christopher L. .
CLINICAL INFECTIOUS DISEASES, 2021, 73 (11) :2112-2115
[4]  
Canaday David H, 2021, medRxiv, DOI 10.1101/2021.12.07.21267179
[5]   Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron [J].
Carreno, Juan Manuel ;
Alshammary, Hala ;
Tcheou, Johnstone ;
Singh, Gagandeep ;
Raskin, Ariel J. ;
Kawabata, Hisaaki ;
Sominsky, Levy A. ;
Clark, Jordan J. ;
Adelsberg, Daniel C. ;
Bielak, Dominika A. ;
Gonzalez-Reiche, Ana Silvia ;
Dambrauskas, Nicholas ;
Vigdorovich, Vladimir ;
Srivastava, Komal ;
Sather, D. Noah ;
Sordillo, Emilia Mia ;
Bajic, Goran ;
van Bakel, Harm ;
Simon, Viviana ;
Krammer, Florian .
NATURE, 2022, 602 (7898) :682-+
[6]   Omicron extensively but incompletely escapes Pfizer BNT162b2 neutralization [J].
Cele, Sandile ;
Jackson, Laurelle ;
Khoury, David S. ;
Khan, Khadija ;
Moyo-Gwete, Thandeka ;
Tegally, Houriiyah ;
San, James Emmanuel ;
Cromer, Deborah ;
Scheepers, Cathrine ;
Amoako, Daniel G. ;
Karim, Farina ;
Bernstein, Mallory ;
Lustig, Gila ;
Archary, Derseree ;
Smith, Muneerah ;
Ganga, Yashica ;
Jule, Zesuliwe ;
Reedoy, Kajal ;
Hwa, Shi-Hsia ;
Giandhari, Jennifer ;
Blackburn, Jonathan M. ;
Gosnell, Bernadett, I ;
Karim, Salim S. Abdool ;
Hanekom, Willem ;
von Gottberg, Anne ;
Bhiman, Jinal N. ;
Lessells, Richard J. ;
Moosa, Mahomed-Yunus S. ;
Davenport, Miles P. ;
de Oliveira, Tulio ;
Moore, Penny L. ;
Sigal, Alex .
NATURE, 2022, 602 (7898) :654-+
[7]   Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants and the impact of boosting: a meta-analysis [J].
Cromer, Deborah ;
Steain, Megan ;
Reynaldi, Arnold ;
Schlub, Timothy E. ;
Wheatley, Adam K. ;
Juno, Jennifer A. ;
Kent, Stephen J. ;
Triccas, James A. ;
Khoury, David S. ;
Davenport, Miles P. .
LANCET MICROBE, 2022, 3 (01) :E52-E61
[8]   Impaired Functional T-Cell Response to SARS-CoV-2 After Two Doses of BNT162b2 mRNA Vaccine in Older People [J].
Demaret, Julie ;
Corroyer-Simovic, Benedicte ;
Alidjinou, Enagnon Kazali ;
Goffard, Anne ;
Trauet, Jacques ;
Miczek, Sophie ;
Vuotto, Fanny ;
Dendooven, Arnaud ;
Huvent-Grelle, Dominique ;
Podvin, Juliette ;
Dreuil, Daniel ;
Faure, Karine ;
Deplanque, Dominique ;
Bocket, Laurence ;
Duhamel, Alain ;
Labreuche, Julien ;
Sobaszek, Annie ;
Hisbergues, Michael ;
Puisieux, Francois ;
Labalette, Myriam ;
Lefevre, Guillaume .
FRONTIERS IN IMMUNOLOGY, 2021, 12
[9]   Severe SARS-CoV-2 patients develop a higher specific T-cell response [J].
Demaret, Julie ;
Lefevre, Guillaume ;
Vuotto, Fanny ;
Trauet, Jacques ;
Duhamel, Alain ;
Labreuche, Julien ;
Varlet, Pauline ;
Dendooven, Arnaud ;
Stabler, Sarah ;
Gachet, Benoit ;
Bauer, Jules ;
Prevost, Brigitte ;
Bocket, Laurence ;
Alidjinou, Enagnon Kazali ;
Lambert, Marc ;
Yelnik, Cecile ;
Meresse, Bertrand ;
Dubuquoy, Laurent ;
Launay, David ;
Dubucquoi, Sylvain ;
Montaigne, David ;
Woitrain, Eloise ;
Maggiotto, Francois ;
Bou Saleh, Mohamed ;
Top, Isabelle ;
Elsermans, Vincent ;
Jeanpierre, Emmanuelle ;
Dupont, Annabelle ;
Susen, Sophie ;
Brousseau, Thierry ;
Poissy, Julien ;
Faure, Karine ;
Labalette, Myriam .
CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2020, 9 (12)
[10]  
Doria-Rose NA, 2021, medRxiv, DOI [10.1101/2021.12.15.21267805, 10.1101/2021.12.15.21267805, DOI 10.1101/2021.12.15.21267805]